-+ 0.00%
-+ 0.00%
-+ 0.00%

BetterLife Pharma appoints Charles Duncan to board, names him audit committee chair

PUBT·08/31/2026 12:04:41
Listen to the news
BetterLife Pharma appoints Charles Duncan to board, names him audit committee chair
  • BetterLife Pharma named Charles Duncan to its board, appointing him chair of the audit committee.
  • Duncan leads biotech strategy and development at Gilmartin Group, advising life sciences companies on corporate strategy and investor engagement.
  • He is a former Wall Street biotechnology analyst, previously a managing director at Cantor Fitzgerald, Piper Jaffray, and JMP Securities.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BetterLife Pharma Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608310800NEWSFILECNPR____20260831_311653_1) on August 31, 2026, and is solely responsible for the information contained therein.